News
36m
ScienceAlert on MSNNew Weight Loss Drug Outperformed Existing Treatment in Clinical Trial
Like semaglutide, the new drug known as ecnoglutide is glucagon-like peptide-1 receptor agonist. In simple terms, they both ...
Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a new dilemma: What happens if they stop taking them? Many worry that they’ll ...
4h
Korea JoongAng Daily on MSNWegovy prescriptions near 400,000 as experts concerned over widespread use, health risks
Prescriptions for popular weight-loss drug Wegovy have soared in Korea, reaching nearly 400,000 just eight months after its launch. But doctors and health officials warn of reckless use far beyond the ...
WITH the price of Mounjaro set to rise and concerns about long-term affordability and access, many may be looking to turn to ...
The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on ...
Patients' vision loss, which is rare according to a new study, is also the subject of multiple lawsuits, including two filed ...
2don MSNOpinion
Voices: Yes, Mounjaro is set to treble in price – but don’t abandon weight-loss jabs until you read this
COMMENT: The monthly cost of a private prescription exceeding £300 from next month is worrying news for the half a million ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...
New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results